Successful Completion of Phase I/II Trial with A9T-1101
NEWS RELEASE Alpha-9 Theranostics Announces Successful Completion of Phase I/II Trial with A9T-1101 in patients with Neuroendocrine Tumours Diagnostic Imaging Candidate Confirms Utility of BF3...